Status:
UNKNOWN
Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Coronary Syndrome and no Significant Coronary Artery Stenosis
Lead Sponsor:
Bartlomiej Guzik
Collaborating Sponsors:
Abbott
Conditions:
Coronary Artery Disease
Ischemia and No Obstructive Coronary Arteries
Eligibility:
All Genders
18-90 years
Brief Summary
Patients with chronic coronary syndromes (CCS) diagnosed without significant lesions in invasive coronary angiography (ischemia non-obstructive coronary artery disease - INOCA) represent approximately...
Eligibility Criteria
Inclusion
- Diagnosed chronic coronary syndrome CCS ≥ 2.
- Evidence of myocardial ischemia (positive result of non-invasive stress test).
- Informed consent.
- Age at least 18 years.
Exclusion
Key Trial Info
Start Date :
July 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05313919
Start Date
July 24 2020
End Date
June 30 2023
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Interventional Cardiology, John Paul II Hospital, Krakow, Poland, Institute Of Cardiology, Jagiellonian University Medical College
Krakow, Lesser Poland Voivodeship, Poland, 31-202